Aggregate data as of May 1, 2026
The Countermeasures Injury Compensation Program (CICP) provides compensation for covered serious injuries or deaths that, based on compelling, reliable, valid, medical and scientific evidence, are found to be directly caused by the administration or use of a covered countermeasure or are determined to meet the requirements of a countermeasure injury table. Temporal association between the administration or use of the covered countermeasure and onset of the injury (i.e., the injury occurs a certain time after the administration or use) is not sufficient, by itself, to prove that an injury is the direct result of a covered countermeasure.
It is important to note that the CICP reports data based on the alleged countermeasure(s) and the alleged injuries that requesters list on their Request for Benefits (RFB) forms or claim. The countermeasure or injury listed by the requester on the RFB may or may not be consistent with the requester’s medical documentation or the injury resulting in compensation. While requesters are required to identify the alleged countermeasure on their RFB form, they are not required to list the specific manufacturer or trade name on their RFB form.
HRSA continues to strengthen its reporting capabilities for CICP data. Ongoing validation, system updates, and reconciliation efforts, such as merging duplicate filings, may result in minor changes to data. The program is committed to transparency and maintaining high standards of data quality and integrity.
CICP data for fiscal years 2010 – 2026 (as of May 1, 2026)
Total CICP claims ever filed: 14,744
- Pending review or in review: 6,978
- Decisions: 7,766
- Claims found eligible for compensation: 142
- Claims compensated: 86
- Claims pending benefits determination: 43
- Claims with no eligible reported expenses: 13
- Denied: 7,624
- Required medical records not submitted: 2,905
- Standard of proof not met and/or covered injury not sustained: 1,640
- Missed filing deadline: 2,661
- Not CICP covered product/not specified: 418
CICP decisions regarding COVID-19 claims
As of May 1, 2026, the CICP has rendered 7,168 decisions on COVID-19 claims. See below for more COVID-19 data on claims filed, administrative and medical eligibility decisions, and benefits determinations.
CICP data for COVID-19 claims (as of May 1, 2026)
Total COVID-19 CICP claims filed: 14,135
- Pending review or in review: 6,967
- Decisions: 7,168
- Claims found eligible for compensation: 102
- Claims compensated: 56
- Claims pending benefits determination: 43
- Claims with no eligible reported expenses: 3
- Denied: 7,066
- Requested medical records not submitted: 2,768
- Standard of proof not met and/or covered injury not sustained: 1,415
- Missed filing deadline: 2,619
- Not CICP covered product/not specified: 264
Detailed CICP claims data
CICP claims data is provided below in categories pertaining to their status.
Table 1. Alleged COVID-19 countermeasure claims filed as of May 1, 2026
Table 2. Pending non-COVID-19 countermeasure claims filed as of May 1, 2026
Table 3. CICP claims pending compensation as of May 1, 2026
Table 4. CICP claims compensated (Fiscal Years 2010 – 2026) as of May 1, 2026
Table 5. CICP claims eligible for compensation, but no eligible reported losses or expenses (Fiscal Years 2010 – 2026) as of May 1, 2026
Table 6. CICP claims denied compensation because required medical records were not submitted (Fiscal Years 2010 – 2026) as of May 1, 2026
Table 7. CICP claims denied compensation for not meeting the standard of proof and/or a covered injury was not sustained (Fiscal Years 2010 – 2026) as of May 1, 2026
Table 8. CICP ineligible claims due to missing the filing deadline (Fiscal Years 2010 – 2026) as of May 1, 2026
Table 9. Ineligible claims for products not covered by the CICP (Fiscal Years 2010 – 2026) as of May 1, 2026
Table 10. CICP ineligible claims due to not alleging any countermeasure administration or use (Fiscal Years 2010 – 2026) as of May 1, 2026